drugset / Trial / NCT01087203
A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the effectiveness and safety of the investigational drug, tanezumab, in adult patients with painful diabetic peripheral neuropathy.
Timeline
- Start
- 2010-03-30
- Primary completion
- 2010-11-18
- Completion
- 2011-07-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tanezumab | Monoclonal antibody | 20 mg | Subcutaneous |